EFdA (Islatravir): An Outstanding Anti-HIV Modified Nucleoside: From Conceptualization to Present-Day Clinical Findings
Author:   Hiroshi Ohrui
Publisher:   Bayshop (Generis Publishing)
ISBN:  

9798892481762


Pages:   68
Publication Date:   09 February 2026
Format:   Paperback
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Our Price $92.40 Quantity:  
Add to Cart

Share |

EFdA (Islatravir): An Outstanding Anti-HIV Modified Nucleoside: From Conceptualization to Present-Day Clinical Findings


Overview

EFdA(4'-C-ethynyl-2-fluoro-2'-deoxyadenosine), named Islatravir by Merck, is a very excellent anti-HIV modified nucleoside. The story of its development, especially the basis of its design, advances in its synthetic methods, amazing clinical results and unexpected clinical results, and further, the possibility of EFdA as the clinical medicine, is described.

Full Product Details

Author:   Hiroshi Ohrui
Publisher:   Bayshop (Generis Publishing)
Imprint:   Bayshop (Generis Publishing)
Dimensions:   Width: 15.20cm , Height: 0.50cm , Length: 22.90cm
Weight:   0.141kg
ISBN:  

9798892481762


Pages:   68
Publication Date:   09 February 2026
Audience:   General/trade ,  General
Format:   Paperback
Publisher's Status:   Active
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Table of Contents

Reviews

Author Information

Tab Content 6

Author Website:  

Countries Available

All regions
Latest Reading Guide

April RG 26_2

 

Shopping Cart
Your cart is empty
 Shopping cart
Mailing List

 

Sign up now